Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Psychiatry Clin Neurosci. 2022 Aug;76(8):361-366. doi: 10.1111/pcn.13372. Epub 2022 May 30.
The genetic relationship between schizophrenia (SCZ) and other nonpsychiatric disorders remains largely unknown. We examined the shared genetic components between these disorders based on multipopulation data sets.
We used two data sets for East Asian (EAS) and European (EUR) samples. SCZ data was based on the Psychiatric Genomics Consortium Asia with our own genome-wide association study for EAS and Psychiatric Genomics Consortium for EUR. Nonpsychiatric data (20 binary traits [mainly nonpsychiatric complex disorders] and 34 quantitative traits [mainly laboratory examinations and physical characteristics]) were obtained from Biobank Japan and UK Biobank for EAS and EUR samples, respectively. To evaluate genetic correlation, linkage disequilibrium score regression analysis was utilized with further meta-analysis for each result from EAS and EUR samples to obtain robust evidence. Subsequent mendelian randomization analysis was also included to examine the causal effect.
A significant genetic correlation between SCZ and several metabolic syndrome (MetS) traits was detected in the combined samples (meta-analysis between EAS and EUR data) (body mass index [r = -0.10, q-value = 1.0 × 10 ], high-density-lipoprotein cholesterol [r = 0.072, q-value = 2.9 × 10 ], blood sugar [r = -0.068, q-value = 1.4 × 10 ], triglycerides [r = -0.052, q-value = 2.4 × 10 ], systolic blood pressure [r = -0.054, q-value = 3.5 × 10 ], and C-reactive protein [r = -0.076, q-value = 7.8 × 10 ]. However, no causal relationship on SCZ susceptibility was detected for these traits based on the mendelian randomization analysis.
Our results indicate shared genetic components between SCZ and MetS traits and C-reactive protein. Specifically, we found it interesting that the correlation between MetS traits and SCZ was the opposite of that expected from clinical studies: this genetic study suggests that SCZ susceptibility was associated with reduced MetS. This implied that MetS in patients with SCZ was not associated with genetic components but with environmental factors, including antipsychotics, lifestyle changes, poor diet, lack of exercise, and living conditions.
精神分裂症(SCZ)与其他非精神疾病之间的遗传关系在很大程度上尚不清楚。我们基于多人群数据集,研究了这些疾病之间的共同遗传成分。
我们使用了东亚(EAS)和欧洲(EUR)两个数据集。SCZ 数据基于亚洲精神疾病基因组学联合会的研究结果,同时我们还进行了东亚人群的全基因组关联研究和欧洲人群的精神疾病基因组学联合会的研究。非精神疾病数据(20 种二分类特征[主要为非精神复杂疾病]和 34 种定量特征[主要为实验室检查和身体特征])分别来自日本生物银行和英国生物银行的 EAS 和 EUR 样本。为了评估遗传相关性,我们利用连锁不平衡评分回归分析,并对 EAS 和 EUR 样本的每个结果进行荟萃分析,以获得稳健的证据。随后还进行了孟德尔随机化分析,以检验因果效应。
在合并样本(EAS 和 EUR 数据的荟萃分析)中,发现 SCZ 与多种代谢综合征(MetS)特征之间存在显著的遗传相关性(体质量指数 [r = -0.10,q 值 = 1.0×10 ],高密度脂蛋白胆固醇 [r = 0.072,q 值 = 2.9×10 ],血糖 [r = 0.068,q 值 1.4×10 ],甘油三酯 [r = 0.052,q 值 2.4×10 ],收缩压 [r = 0.054,q 值 3.5×10 ],C 反应蛋白 [r = 0.076,q 值 7.8×10 ])。然而,基于孟德尔随机化分析,并未发现这些特征与 SCZ 易感性之间存在因果关系。
我们的结果表明 SCZ 与 MetS 特征和 C 反应蛋白之间存在共同的遗传成分。具体来说,我们发现一个有趣的现象,即 MetS 特征与 SCZ 之间的相关性与临床研究的预期相反:这项遗传研究表明,SCZ 易感性与 MetS 减少有关。这意味着 SCZ 患者的 MetS 与遗传成分无关,而与环境因素有关,包括抗精神病药物、生活方式改变、不良饮食、缺乏运动和生活条件。